Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing

  • Wolff Schmiegel
  • , Rodney J. Scott
  • , Susan Dooley
  • , Wendy Lewis
  • , Cliff J. Meldrum
  • , Peter Pockney
  • , Brian Draganic
  • , Steve Smith
  • , Chelsee Hewitt
  • , Hazel Philimore
  • , Amanda Lucas
  • , Elva Shi
  • , Kateh Namdarian
  • , Timmy Chan
  • , Danilo Acosta
  • , Su Ping-Chang
  • , Andrea Tannapfel
  • , Anke Reinacher-Schick
  • , Waldemar Uhl
  • , Christian Teschendorf
    • Heiner Wolters, Josef Stern, Richard Viebahn, Helmut Friess, Klaus Peter Janssen, Ulrich Nitsche, Julia Slotta-Huspenina, Michael Pohl, Deepak Vangala, Alexander Baraniskin, Barbara Dockhorn-Dworniczak, Susanne Hegewisch-Becker, Philippe Ronga, Daniel L. Edelstein, Frederick S. Jones, Stephan Hahn, Stephen B. Fox

Research output: Contribution to journal › Article › peer-review

133 Scopus citations

Fingerprint

Dive into the research topics of 'Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology